Title Management of recurrent alveolar soft-part sarcoma of the tongue after external beam radiotherapy with iodine-125 seed brachytherapy
Authors Meng, Na
Zhang, Xiaomeng
Liao, Anyan
Tian, Suqing
Ran, Weiqiang
Gao, Yang
Wang, Jun Jie
Affiliation Peking Univ Third Hosp, Dept Radiat Oncol, Beijing 100191, Peoples R China.
Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Adv Med Imaging Sci, Boston, MA 02115 USA.
Peking Univ Third Hosp, Dept Ultrasound, Beijing 100191, Peoples R China.
Keywords I-125 seed
brachytherapy
ultrasound guidance
alveolar soft-part sarcoma
outcome
IMPLANTATION
CHILDREN
HEAD
NECK
Issue Date 2014
Publisher head and neck journal for the sciences and specialties of the head and neck
Citation HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK.2014,36,(12),E125-E128.
Abstract BackgroundAlveolar soft part sarcoma (ASPS) is a rare type of soft tissue sarcoma. The infrequency of ASPS is such that it accounts for <1% of all soft tissue sarcomas and <0.1% of sarcomas concerning the head and neck, primarily those involving the orbit (48%) and tongue (25%). Traditional chemotherapy or radiotherapy of ASPS is often associated with poor outcome, even after comprehensive interventions. Methods and ResultsWe performed iodine-125 (I-125) seed brachytherapy under ultrasound guidance through a submandibular puncture in a 4-year-old boy with recurrent ASPS of the tongue. The prescription dose was 120 Gy; therefore, 35 I-125 seeds were implanted with 0.77 mCi per seed, the total amount of activity being 26.95 mCi. CT scans confirmed a complete response after the treatment. ConclusionOur patient now has a recurrent-free survival of >30 months, an amount of time longer than the median rate described in the literature. (c) 2014 Wiley Periodicals, Inc. Head Neck 36: E125-E128, 2014
URI http://hdl.handle.net/20.500.11897/189420
ISSN 1043-3074
DOI 10.1002/hed.23648
Indexed SCI(E)
PubMed
Appears in Collections: 第三医院

Web of Science®


13

Checked on Last Week

Scopus®



Checked on Current Time

百度学术™


0

Checked on Current Time

Google Scholar™





License: See PKU IR operational policies.